These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 33579029)

  • 1. Strategies to Target ADAM17 in Disease: From its Discovery to the iRhom Revolution.
    Calligaris M; Cuffaro D; Bonelli S; Spanò DP; Rossello A; Nuti E; Scilabra SD
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33579029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.
    Moss ML; Minond D
    Mediators Inflamm; 2017; 2017():9673537. PubMed ID: 29230082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iRhom2: An Emerging Adaptor Regulating Immunity and Disease.
    Al-Salihi MA; Lang PA
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status update on iRhom and ADAM17: It's still complicated.
    Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A
    Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The iRhom homology domain is indispensable for ADAM17-mediated TNFα and EGF receptor ligand release.
    Düsterhöft S; Kahveci-Türköz S; Wozniak J; Seifert A; Kasparek P; Ohm H; Liu S; Kopkanova J; Lokau J; Garbers C; Preisinger C; Sedlacek R; Freeman M; Ludwig A
    Cell Mol Life Sci; 2021 Jun; 78(11):5015-5040. PubMed ID: 33950315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.
    Matthews AL; Noy PJ; Reyat JS; Tomlinson MG
    Platelets; 2017 Jun; 28(4):333-341. PubMed ID: 27256961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains.
    Tang B; Li X; Maretzky T; Perez-Aguilar JM; McIlwain D; Xie Y; Zheng Y; Mak TW; Weinstein H; Blobel CP
    FASEB J; 2020 Apr; 34(4):4956-4969. PubMed ID: 32103528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.
    Shimoda M; Horiuchi K; Sasaki A; Tsukamoto T; Okabayashi K; Hasegawa H; Kitagawa Y; Okada Y
    EBioMedicine; 2016 Mar; 5():114-24. PubMed ID: 27077118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex.
    Künzel U; Grieve AG; Meng Y; Sieber B; Cowley SA; Freeman M
    Elife; 2018 Jun; 7():. PubMed ID: 29897336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structural model of the iRhom-ADAM17 sheddase complex reveals functional insights into its trafficking and activity.
    Kahveci-Türköz S; Bläsius K; Wozniak J; Rinkens C; Seifert A; Kasparek P; Ohm H; Oltzen S; Nieszporek M; Schwarz N; Babendreyer A; Preisinger C; Sedlacek R; Ludwig A; Düsterhöft S
    Cell Mol Life Sci; 2023 Apr; 80(5):135. PubMed ID: 37119365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE.
    Oikonomidi I; Burbridge E; Cavadas M; Sullivan G; Collis B; Naegele H; Clancy D; Brezinova J; Hu T; Bileck A; Gerner C; Bolado A; von Kriegsheim A; Martin SJ; Steinberg F; Strisovsky K; Adrain C
    Elife; 2018 Jun; 7():. PubMed ID: 29897333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting ADAM17 Sheddase Activity in Cancer.
    Rossello A; Nuti E; Ferrini S; Fabbi M
    Curr Drug Targets; 2016; 17(16):1908-1927. PubMed ID: 27469341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The iRhom2/ADAM17 Axis Attenuates Bacterial Uptake by Phagocytes in a Cell Autonomous Manner.
    Seifert A; Wozniak J; Düsterhöft S; Kasparek P; Sedlacek R; Dreschers S; Orlikowsky TW; Yildiz D; Ludwig A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17.
    Maney SK; McIlwain DR; Polz R; Pandyra AA; Sundaram B; Wolff D; Ohishi K; Maretzky T; Brooke MA; Evers A; Vasudevan AA; Aghaeepour N; Scheller J; Münk C; Häussinger D; Mak TW; Nolan GP; Kelsell DP; Blobel CP; Lang KS; Lang PA
    Sci Signal; 2015 Nov; 8(401):ra109. PubMed ID: 26535007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer.
    Schumacher N; Rose-John S
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119141. PubMed ID: 34610348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells.
    Sieber B; Lu F; Stribbling SM; Grieve AG; Ryan AJ; Freeman M
    J Cell Sci; 2022 Sep; 135(17):. PubMed ID: 35971826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Molecular Determinants in iRhoms1 and 2 That Contribute to the Substrate Selectivity of Stimulated ADAM17.
    Zhao Y; Dávila EM; Li X; Tang B; Rabinowitsch AI; Perez-Aguilar JM; Blobel CP
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond.
    Saad MI; Jenkins BJ
    FEBS J; 2024 Jan; 291(1):10-24. PubMed ID: 37540030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
    Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
    J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iRhom2 regulates ectodomain shedding and surface expression of the major histocompatibility complex (MHC) class I.
    Calligaris M; Spanò DP; Bonelli S; Müller SA; Carcione C; D'apolito D; Amico G; Miele M; Di Bella M; Zito G; Nuti E; Rossello A; Blobel CP; Lichtenthaler SF; Scilabra SD
    Cell Mol Life Sci; 2024 Apr; 81(1):163. PubMed ID: 38570362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.